The Trump administration has promised that addressing childhood obesity will be a key part of its “Make America Healthy Again ...

Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...

CHILDREN as young as ten have had hip replacements on the NHS because they are so fat, shock figures show. They are going under the knife as childhood obesity levels soar, with one in three now ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

George Jones of UpScript Health discusses telemedicine's evolution from basic e-prescribing to real-time video consultations, ...

Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

There is a silent 'pandemic' that is taking over the world, including India, and costing lives—obesity. World Obesity Atlas ...

Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...